The immunoglobulin (IgG)-mediated inhibition of hemoglobin synthesis or complement-binding and direct cytotoxic effects on erythroblasts were found in patients with PRCA, wherein some patients, the inhibitory antibodies were directed against erythropoietin [20]. The gene discussed is EPO; the disease is pure red-cell aplasia.